首页> 外文OA文献 >>Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

【2h】

>Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

机译：>α-突触核蛋白和载脂蛋白E作为脑脊液中潜在生物标志物的评价，以监测多巴胺疾病和精神分裂症的多巴胺型疾病状态中药物治疗疗效的潜在生物标志物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ashish Kumar Gupta; Ruchika Pokhriyal; Uddipan Das; Mohd Imran Khan; Domada Ratna Kumar; Rishab Gupta; Rakesh Kumar Chadda; Rashmi Ramachandran; Vinay Goyal; Manjari Tripathi; Gururao Hariprasad;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia [J] . Ashish Kumar Gupta, Ruchika Pokhriyal, Uddipan Das, Neuropsychiatric Disease and Treatment . 2019,第6期

机译：评价α-突触核蛋白和载脂蛋白E作为脑脊液中潜在的生物标志物，以监测多巴胺指示的帕金森病和精神分裂症的疾病状态下的药物治疗功效
2. Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia [J] . Ashish Kumar Gupta, Ruchika Pokhriyal, Mohd Imran Khan, Neuropsychiatric Disease and Treatment . 2019,第6期

机译：脑脊液蛋白质组学鉴定α2-巨球蛋白作为监测多巴胺定型帕金森氏病和精神分裂症的药理功效的潜在生物标志物
3. 2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia [J] . Ashish Kumar Gupta, Gaurav Khunger Kumar, Komal Rani, Neuropsychiatric Disease and Treatment . 2019,第3期

机译：2D-DIGE作为识别血清蛋白生物标志物以监测多巴胺决定的帕金森氏病和精神分裂症状态的药理作用的策略
4. Development and Clinical Validation of Alpha-Synuclein Peptides as Parkinson's Disease Diagnostic Biomarkers [C] . Christine A. Jelinek, Liana S. Rosenthal, Yan Jia, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：α-突触核蛋白肽作为帕金森病诊断生物标志物的开发和临床验证
5. Design, synthesis, biological evaluation and molecular modeling studies of novel multifunctional neuroprotective drugs for the treatment of Parkinson's disease: An effort towards the improvement of in vivo efficacy and modulation of alpha synuclein aggregation property of the neuroprotective parent molecule (d-264) [D] . Modi, Gyan Prakash 2013

机译：用于治疗帕金森氏病的新型多功能神经保护药物的设计，合成，生物学评估和分子模型研究：努力提高神经保护母体分子（d-264）的体内功效和调节α突触核蛋白聚集特性的努力
6. Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia [O] . Ashish Kumar Gupta, Ruchika Pokhriyal, Uddipan Das, 2019

机译：评价α-突触核蛋白和载脂蛋白E作为脑脊液中的潜在生物标记物以监测多巴胺指示的帕金森氏病和精神分裂症的疾病状态下的药物治疗功效
7. >2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinsonrsquo;s disease and schizophrenia [O] . Ashish Kumar Gupta, Gaurav Khunger Kumar, Komal Rani, 2019

机译：> 2D-Dige作为鉴定血清蛋白生物标志物的策略，以监测帕金森氏病和精神分裂症的多巴胺症状态中的药理效果

>Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

著录项

引文网络

相似文献

相关主题

期刊订阅